HR 501 United States House · 118th Congress

Block, Report, and Suspend Suspicious Shipments Act

This bill requires pharmacies and drug distributors to investigate suspicious orders of controlled substances. If they identify signs drugs might be diverted to illegal use, they must document their investigation, report to the DEA, and may decline the order. However, if they resolve all concerns, they can fill the order without reporting to the DEA. The DEA will define specific warning signs within one year, and the rules take effect one year after enactment.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
President
Introduced Jan 25, 2023 Last action May 17, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
11
Key actions
6
Committee
8
Amendments
1
May 17, 2023
Lower · Passed
Committee on the Judiciary discharged.
lower
May 17, 2023
Lower · Passed
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-66, Part I.
lower
Mar 24, 2023
Introduced
Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
lower
Mar 24, 2023
Lower · Passed
Committee Consideration and Mark-up Session Held.
lower
Mar 23, 2023
Lower · Passed
Committee Consideration and Mark-up Session Held.
lower
Mar 8, 2023
Lower · Passed
Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 28 - 0 .
lower
Mar 8, 2023
Lower · Passed
Subcommittee Consideration and Mark-up Session Held.
lower
Jan 25, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jan 25, 2023
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jan 25, 2023
Introduced
Introduced in House
lower
1 primary · 7 co-sponsors

Sponsors